Associated Papers
Genetics and clinical characteristics of Korean patients with bilateral macronodular adrenocortical disease.
Park SS et al.
European Journal of Endocrinology, 2026
A Global Approach to the Long-Term Follow-up of 17 Families with Bilateral Macronodular Adrenal Disease.
Charchar HLS et al.
The Journal of Clinical Endocrinology and Metabolism, 2025
Advancements in the research of the structure, function, and disease-related roles of ARMC5.
Qu Y et al.
Frontiers of Medicine, 2025
The mutational landscape of ARMC5 in Primary Bilateral Macronodular Adrenal Hyperplasia: an update.
Bouys L et al.
Orphanet Journal of Rare Diseases, 2025
Somatic Molecular Heterogeneity in Bilateral Macronodular Adrenocortical Disease (BMAD) Differs Among the Pathological Subgroups.
Violon F et al.
Endocrine Pathology, 2024
ARMC5 mutations are associated with high levels of proliferating cell nuclear antigen and the presence of the serotonin receptor 5HT4R in PMAH nodules.
Conceição BBD et al.
Archives of Endocrinology and Metabolism, 2020
Molecular mechanisms of ARMC5 mutations in adrenal pathophysiology.
Stratakis CA et al.
Current Opinion in Endocrine and Metabolic Research, 2019
[Hereditary Cushing's syndrome caused by primary bilateral macronodular adrenal hyperplasia due to ARMC5 mutation with concomitant primary hyperparathyroidism: the first known case in Russia].
Mamedova EO et al.
Problemy Endokrinologii, 2019
A multicenter experience on the prevalence of ARMC5 mutations in patients with primary bilateral macronodular adrenal hyperplasia: from genetic characterization to clinical phenotype.
Albiger NM et al.
Endocrine, 2017
ARMC5 mutation in a Portuguese family with primary bilateral macronodular adrenal hyperplasia (PBMAH).
Rego T et al.
Endocrinology, Diabetes & Metabolism Case Reports, 2017
ARMC5 mutations are a frequent cause of primary macronodular adrenal Hyperplasia.
Alencar GA et al.
The Journal of Clinical Endocrinology and Metabolism, 2014
Select a paper to view details